4
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9925 | Ofatumumab | Others | |
Ofatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation | |||
T76821 | Ocaratuzumab | ||
Ocaratuzumab (AME 133v), an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, demonstrates enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) [1] [2] with a dissociation constant (Kd) of approximatel... | |||
T77183 | Ripertamab | ||
Ripertamab (SCT400), a recombinant human-mouse chimeric anti-CD20 IgG1κ monoclonal antibody (mAb), has applications in the research of hematological malignancies, particularly non-Hodgkin’s lymphoma (NHL) [1]. | |||
T76765 | Veltuzumab | ||
Veltuzumab (IMMU-106), a humanized anti-CD20 monoclonal antibody, exhibits a low EC50 value ranging from 0.08 to 0.09 μg/mL in the Daudi cell line. It is used in cancer research, specifically for non-Hodgkin lymphoma (NH... |